Torrent Pharma Stock - Sunday background on the Indian drug maker
21.06.2026 - 20:18:36 | ad-hoc-news.de
Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 20:17 IST. Details in the imprint.
Torrent Pharma (INE685A01028) is one of India's established pharmaceutical groups with listings on both the National Stock Exchange and the Bombay Stock Exchange. This Sunday background takes stock of the company's evolution, ownership and business profile based on public filings and market data.
Background and data on Torrent Pharma stock
All company news, regulatory filings and market data on Torrent Pharmaceuticals can be found in the dedicated topic section and on the firm's investor-relations pages.
How Torrent Pharma is positioned
Torrent Pharmaceuticals traces its roots back to the 1950s as part of the broader Torrent Group founded by the late U.N. Mehta and later led by Samir Mehta. The group gradually shifted from textiles and engineering toward formulations and branded generics.
According to the company history, Torrent Pharma became a public company and listed its equity shares on the BSE and later the NSE, expanding its reach beyond Gujarat to pan-India markets. Over time it has built meaningful positions in cardiology, central nervous system, gastro-intestinal and diabetology therapies.
Background and governance today
The promoter family continues to control a majority stake in Torrent Pharma, with institutional investors and mutual funds holding significant minority positions according to exchange shareholding patterns. The board includes executive family members alongside independent directors with pharmaceutical and financial backgrounds.
Corporate governance is structured around board committees for audit, nomination and remuneration, and risk management that supervise internal controls and compliance with Indian listing regulations, as set out in the firm's annual report. On balance, this framework is in line with other large Indian pharma peers.
The product behind the stock
Torrent Pharma's business centers on branded generics and specialty drugs in India and selected international markets, with key products across chronic therapies such as cardiovascular and central nervous system treatments, alongside a growing presence in nephrology and oncology. The company also operates manufacturing plants and a pipeline of new formulations.
Where the stock trades today
The shares of Torrent Pharma (INE685A01028) last traded on the National Stock Exchange of India at around INR 4,430 on 06/19/2026 during regular market hours, according to recent quote data from Indian exchange sources.
Key facts on Torrent Pharma stock
- Company: Torrent Pharmaceuticals Ltd.
- ISIN: INE685A01028
- WKN: 500420
- Ticker: TORNTPHARM
- Venue: NSE
- Price (as of 06/19/2026, 15:58 IST): 4,429.80 INR
- Market cap: data not independently verified today
- Sector / Industry: Pharmaceuticals & Drugs
- Index membership: data not independently verified today
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
